Experts from Vanderbilt University School of Medicine’s Department of Health Policy and Vanderbilt University’s Peabody College of Education and Human Development are joining efforts to establish a Policies for Action (P4A) Research Hub at Vanderbilt to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including those in immigrant families and with prenatal exposure to opioids.

Katherine Swartz, PhD, a nationally known leader in health policy research, encouraged others conducting investigations in the field to move beyond the data and into local communities to gather the stories behind the data during last week’s Research into Policy and Practice Lecture hosted by Vanderbilt University Medical Center’s Department of Health Policy.

While there has been much effort to control spending for individuals eligible for both Medicaid and Medicare in the United States, for the first time a team of Vanderbilt health policy researchers have analyzed spending trends for this population over a multiyear period in order to gain a much clearer understanding of exactly how much is being spent and by whom.

As both drug prices and out-of-pocket expense for prescription medications continue to climb, a team of Health Policy experts at Vanderbilt University School of Medicine (VUSM) have received a grant to determine if these factors are causing older Americans enrolled in Medicare Part D for medication coverage to delay or never fill their prescriptions.

Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.

A new study from researchers at Vanderbilt and Harvard universities, published this week in the journal Health Affairs, uses federal health survey data to evaluate community-based efforts to address smoking, obesity and other health conditions such as type 2 diabetes and hypertension.

A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children, but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit to patients in most cases.